Dr. Michael Behring

T32 CPCTP Post-doctoral Fellow (03/01/2019)

Dr. Michael Behring is a Postdoctoral fellow in the Department of Pathology at the University of Alabama at Birmingham under the mentorship of Dr. Upender Manne. With a background in molecular epidemiology, social science and information science, Michael’s research approach considers both the biological and social bases of cancer health disparities. Michael’s long-term career goal is to become a successful independent researcher as a cancer epidemiologist with an eye toward applying results to his community.

Dr. Karina Halilova

T32 CPCTP Post-doctoral Fellow (07/01/2019)

Dr. Halilova is a postdoctoral research fellow in the Division of Preventive Medicine at the University of Alabama at Birmingham (UAB). With the support of the Cancer Prevention and Control Training Program (CPCTP) and fellowship, she is gaining the experience and intensive training she needs to achieve her long-term career objective of becoming an independent physician-scientist. This training allows her to develop an expertise in designing, implementing and testing healthy lifestyle interventions for cancer survivors. 

Dr. Anna Hoppmann

T32 CPCTP Post-doctoral Fellow (01/01/2020)

Dr. Hoppmann joined the Cancer Prevention and Control Training Program on January 1, 2020. She is a pediatric physician, currently receiving subspecialty training as a second year fellow in pediatric hematology and oncology. Her prior work focuses on measuring and improving adherence to oral chemotherapy for children with leukemia, and under this grant, her original research abstract on adherence was accepted by the American Society of Clinical Oncology conference and awarded a 2020 Conquer Cancer Foundation Merit Award. 

Anna Junkins

T32 CPCTP Pre-doctoral Fellow (01/01/2020)

Ms. Anna Junkins became a pre-doctoral trainee January 1, 2020. As a second-year PhD student in Epidemiology, she has completed over half of the required coursework and passed the first-year qualifying exam. Her coursework over the last year included advanced statistical methods, analyses of case-control and cohort study designs, categorical data analysis, qualitative and mixed methods research in public health, and scientific integrity. In addition to her required coursework, she completed an international, doctoral-level course on HPV molecular biology and global health offered by the Karolinska Institute in Sweden.

Andrew Brane

T32 CPCTP Pre-doctoral Fellow (06/01/2020)

Mr. Andrew Brane became a pre-doctoral trainee June 1, 2020. After joining the Biology department as a Master’s student in the Spring of 2018, his commitment to both coursework and research swiftly moved him onto the PhD track. Upon admission into the CPCTP program, he had already completed a majority of his department’s coursework, including courses on biostatistics, teaching, and responsible conduct of research. 

Dr. Carly Bess Williams Scalise

T32 CPCTP Post-doctoral Fellow (07/01/2020)

Dr. Carly Bess Scalise is a Postdoctoral Fellow in the Department of OB/GYN - Gynecologic Oncology at the University of Alabama at Birmingham (UAB) under the mentorship of Rebecca Arend, MD and Lyse Norian, PhD. With a background in cell and molecular pharmacology, experimental therapeutics, and immunotherapy, Carly Bess’s research approach considers both tumor intrinsic and immune drivers of cancer. 

Jami Anderson

T32 CPCTP Pre-doctoral Fellow (08/01/2020)

Ms. Anderson is a pre-doctoral fellow and is a third-year doctoral student in the research track of the PhD program in Health Services Administration in the School of Health Professions, University of Alabama at Birmingham. In addition to required coursework for her PhD program, Ms. Anderson will be completing a graduate certificate in Applications of Mixed Methods Research in the summer of 2020 at UAB. During the PhD program, she has had opportunities to develop her research skills including qualitative and mixed methods research through projects related to traumatic experiences, mental health, chronic disease (e.g., cancer survivors), lifestyle choices, and health outcomes.